Single-isomer Levalbuterol: a Review of the Acute Data

Overview

Journal Curr Allergy Asthma Rep

Specialties Allergy & Immunology
Pulmonary Medicine

Date 2003 Feb 4

PMID 12562558

Citations 5

Authors

Richard Nowak

Affiliations

Soon will be listed here.

Abstract

Levalbuterol, the pure (R)-isomer of racemic albuterol, is a new therapeutic option for patients with asthma. Racemic albuterol comprises a 50:50 mixture of (R)- and (S)-albuterol, with (R)-albuterol conferring all of the bronchodilator effects of the racemate. Numerous preclinical and in vitro studies have indicated that (S)-albuterol is not an inert isomer, but may have proinflammatory effects. Results from clinical trials in adults and children with asthma have demonstrated that 0.63 mg levalbuterol provides effective bronchodilation with lower b-mediated side effects compared with 2.5 mg racemic albuterol. In the emergency department, levalbuterol provided greater bronchodilation and significantly reduced hospital admissions compared with racemic albuterol. Recent studies have supported that levalbuterol use in acute settings may reduce the cost of asthma treatment by decreasing the total treatments and subsequent respiratory therapy resources. Levalbuterol provides heath care professionals with a safe, effective, and potentially cost-saving alternative to racemic albuterol for the treatment of patients with asthma.

Citing Articles

Chiral drugs: an overview.

Nguyen L, He H, Pham-Huy C Int J Biomed Sci. 2013; 2(2):85-100.

PMID: 23674971 PMC: 3614593.

Management of severe asthma exacerbation in children.

Wang X, Hong J World J Pediatr. 2011; 7(4):293-301.

PMID: 22015722 DOI: 10.1007/s12519-011-0325-1.

Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma.

Lundblad L, Rinaldi L, Poynter M, Riesenfeld E, Wu M, Aimi S Respir Res. 2011; 12:27.

PMID: 21385381 PMC: 3060863. DOI: 10.1186/1465-9921-12-27.

Acute severe asthma: new approaches to assessment and treatment.

Papiris S, Manali E, Kolilekas L, Triantafillidou C, Tsangaris I Drugs. 2009; 69(17):2363-91.

PMID: 19911854 DOI: 10.2165/11319930-000000000-00000.

Effects of albuterol isomers on the contraction and Ca2+ signaling of small airways in mouse lung slices.

Delmotte P, Sanderson M Am J Respir Cell Mol Biol. 2007; 38(5):524-31.

PMID: 18063837 PMC: 2335335. DOI: 10.1165/rcmb.2007-0214OC.

References

McCarren M, Zalenski R, McDermott M, Kaur K . Predicting recovery from acute asthma in an emergency diagnostic and treatment unit. Acad Emerg Med. 2000; 7(1):28-35. DOI: 10.1111/j.1553-2712.2000.tb01887.x. View

Ducharme F, Kramer M . Relapse following emergency treatment for acute asthma: can it be predicted or prevented?. J Clin Epidemiol. 1993; 46(12):1395-402. DOI: 10.1016/0895-4356(93)90139-r. View

Milgrom H, Skoner D, Bensch G, Kim K, Claus R, Baumgartner R . Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol. 2001; 108(6):938-45. DOI: 10.1067/mai.2001.120134. View

Cockcroft D, Swystun V . Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. Thorax. 1997; 52(10):845-8. PMC: 1758422. DOI: 10.1136/thx.52.10.845. View

Barnes P . Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol. 1999; 104(2 Pt 2):S10-7. DOI: 10.1016/s0091-6749(99)70269-1. View

Yamaguchi H, McCullough J . S-albuterol exacerbates calcium responses to carbachol in airway smooth muscle cells. Clin Rev Allergy Immunol. 1996; 14(1):47-55. DOI: 10.1007/BF02772202. View

PERRIN-FAYOLLE M . Salbutamol in the treatment of asthma. Lancet. 1995; 346(8982):1101. DOI: 10.1016/s0140-6736(95)91775-6. View

Kellerman D, DeGraw S, Koch P, Jusko W . Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers. J Clin Pharmacol. 2001; 38(12):1096-106. View

Mitra S, Ugur M, Ugur O, Goodman H, McCullough J, Yamaguchi H . (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol. 1998; 53(3):347-54. DOI: 10.1124/mol.53.3.347. View

10.

Dhand R, Goode M, Reid R, FINK J, FAHEY P, Tobin M . Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol. Am J Respir Crit Care Med. 1999; 160(4):1136-41. DOI: 10.1164/ajrccm.160.4.9812074. View

11.

Boulton D, Fawcett J . Enantioselective disposition of albuterol in humans. Clin Rev Allergy Immunol. 1996; 14(1):115-38. DOI: 10.1007/BF02772207. View

12.

McDowell K, Chatburn R, Myers T, ORiordan M, Kercsmar C . A cost-saving algorithm for children hospitalized for status asthmaticus. Arch Pediatr Adolesc Med. 1998; 152(10):977-84. DOI: 10.1001/archpedi.152.10.977. View

13.

Lin R, Pesola G, Bakalchuk L, Morgan J, Heyl G, Freyberg C . Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial. Ann Emerg Med. 1998; 31(2):208-13. DOI: 10.1016/s0196-0644(98)70308-7. View

14.

Emerman C . Relapse following treatment of acute asthma in the emergency department. J Asthma. 2001; 37(8):701-8. DOI: 10.3109/02770900009087309. View

15.

Asmus M, Hendeles L, Weinberger M, Ahrens R, Bisgaard H, Lotvall J . Levalbuterol has not been established to have therapeutic advantage over racemic albuterol. J Allergy Clin Immunol. 2002; 110(2):325; author reply 325-8. DOI: 10.1067/mai.2002.126375. View

16.

Gawchik S, Saccar C, Noonan M, Reasner D, DeGraw S . The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. J Allergy Clin Immunol. 1999; 103(4):615-21. DOI: 10.1016/s0091-6749(99)70233-2. View

17.

Nelson H . Beta-adrenergic bronchodilators. N Engl J Med. 1995; 333(8):499-506. DOI: 10.1056/NEJM199508243330807. View

18.

Kellerman D, DeGraw S, Koch P, Jusko W . Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects. Pulm Pharmacol Ther. 1999; 12(6):353-62. DOI: 10.1006/pupt.1999.0217. View

19.

Walle T, Eaton E, Walle U, Pesola G . Stereoselective metabolism of RS-albuterol in humans. Clin Rev Allergy Immunol. 1996; 14(1):101-13. DOI: 10.1007/BF02772206. View

20.

Cho S, Hartleroad J, Oh C . (S)-albuterol increases the production of histamine and IL-4 in mast cells. Int Arch Allergy Immunol. 2001; 124(4):478-84. DOI: 10.1159/000053783. View